Magnézium-szulfát intravénás adása után bekövetkezö cardiorespiratoricus és elektrolit változások status asthmaticusban.

Translated title of the contribution: Cardiorespiratory and electrolytic changes in status asthmaticus after intravenous administration of magnesium sulfate

P. Barzó, B. Bíró, E. Lipták, A. Gyurcsik, P. Barzó, T. Szabó

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The authors studied cardiorespiratory effects of MgSO4 infusion in 30 randomized patients with status asthmaticus. They found, that after having the drug administered, values of VC, FEV1, FIV1, PaO2 and pH increased, the respiratory and heart rate, diastolic blood pressure reduced. Other ventilation, blood gas and ECG parameters were unchanged. Among the electrolytes, serum Ca2+ level has reduced, both plasma and intracellular Mg2+ concentrations increased. It is apparent from the results, that broncholytical ability of MgSO4 given in therapeutical dose i.v. does not reach the level of beta-stimulating agents. However, this completed with the cardioprotective, sedative effect as well as more advantageous ion-distribution, influences favourably the asthmatic dyspnoea.

Original languageHungarian
Pages (from-to)1577-1580
Number of pages4
JournalOrvosi Hetilap
Volume134
Issue number29
Publication statusPublished - Jul 18 1993

Fingerprint

Status Asthmaticus
Magnesium Sulfate
Intravenous Administration
Blood Pressure
Respiratory Rate
Hypnotics and Sedatives
Dyspnea
Electrolytes
Ventilation
Electrocardiography
Heart Rate
Gases
Ions
Serum
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Magnézium-szulfát intravénás adása után bekövetkezö cardiorespiratoricus és elektrolit változások status asthmaticusban. / Barzó, P.; Bíró, B.; Lipták, E.; Gyurcsik, A.; Barzó, P.; Szabó, T.

In: Orvosi Hetilap, Vol. 134, No. 29, 18.07.1993, p. 1577-1580.

Research output: Contribution to journalArticle

Barzó, P. ; Bíró, B. ; Lipták, E. ; Gyurcsik, A. ; Barzó, P. ; Szabó, T. / Magnézium-szulfát intravénás adása után bekövetkezö cardiorespiratoricus és elektrolit változások status asthmaticusban. In: Orvosi Hetilap. 1993 ; Vol. 134, No. 29. pp. 1577-1580.
@article{c8d3e635177e4e2c950940a6f0682cb9,
title = "Magn{\'e}zium-szulf{\'a}t intrav{\'e}n{\'a}s ad{\'a}sa ut{\'a}n bek{\"o}vetkez{\"o} cardiorespiratoricus {\'e}s elektrolit v{\'a}ltoz{\'a}sok status asthmaticusban.",
abstract = "The authors studied cardiorespiratory effects of MgSO4 infusion in 30 randomized patients with status asthmaticus. They found, that after having the drug administered, values of VC, FEV1, FIV1, PaO2 and pH increased, the respiratory and heart rate, diastolic blood pressure reduced. Other ventilation, blood gas and ECG parameters were unchanged. Among the electrolytes, serum Ca2+ level has reduced, both plasma and intracellular Mg2+ concentrations increased. It is apparent from the results, that broncholytical ability of MgSO4 given in therapeutical dose i.v. does not reach the level of beta-stimulating agents. However, this completed with the cardioprotective, sedative effect as well as more advantageous ion-distribution, influences favourably the asthmatic dyspnoea.",
author = "P. Barz{\'o} and B. B{\'i}r{\'o} and E. Lipt{\'a}k and A. Gyurcsik and P. Barz{\'o} and T. Szab{\'o}",
year = "1993",
month = "7",
day = "18",
language = "Hungarian",
volume = "134",
pages = "1577--1580",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - Magnézium-szulfát intravénás adása után bekövetkezö cardiorespiratoricus és elektrolit változások status asthmaticusban.

AU - Barzó, P.

AU - Bíró, B.

AU - Lipták, E.

AU - Gyurcsik, A.

AU - Barzó, P.

AU - Szabó, T.

PY - 1993/7/18

Y1 - 1993/7/18

N2 - The authors studied cardiorespiratory effects of MgSO4 infusion in 30 randomized patients with status asthmaticus. They found, that after having the drug administered, values of VC, FEV1, FIV1, PaO2 and pH increased, the respiratory and heart rate, diastolic blood pressure reduced. Other ventilation, blood gas and ECG parameters were unchanged. Among the electrolytes, serum Ca2+ level has reduced, both plasma and intracellular Mg2+ concentrations increased. It is apparent from the results, that broncholytical ability of MgSO4 given in therapeutical dose i.v. does not reach the level of beta-stimulating agents. However, this completed with the cardioprotective, sedative effect as well as more advantageous ion-distribution, influences favourably the asthmatic dyspnoea.

AB - The authors studied cardiorespiratory effects of MgSO4 infusion in 30 randomized patients with status asthmaticus. They found, that after having the drug administered, values of VC, FEV1, FIV1, PaO2 and pH increased, the respiratory and heart rate, diastolic blood pressure reduced. Other ventilation, blood gas and ECG parameters were unchanged. Among the electrolytes, serum Ca2+ level has reduced, both plasma and intracellular Mg2+ concentrations increased. It is apparent from the results, that broncholytical ability of MgSO4 given in therapeutical dose i.v. does not reach the level of beta-stimulating agents. However, this completed with the cardioprotective, sedative effect as well as more advantageous ion-distribution, influences favourably the asthmatic dyspnoea.

UR - http://www.scopus.com/inward/record.url?scp=0027919816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027919816&partnerID=8YFLogxK

M3 - Article

C2 - 8336927

AN - SCOPUS:0027919816

VL - 134

SP - 1577

EP - 1580

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -